Simon Walker : Citation Profile


Are you Simon Walker?

5

H index

2

i10 index

103

Citations

RESEARCH PRODUCTION:

17

Articles

10

Papers

RESEARCH ACTIVITY:

   11 years (2010 - 2021). See details.
   Cites by year: 9
   Journals where Simon Walker has often published
   Relations with other researchers
   Recent citing documents: 9.    Total self citations: 10 (8.85 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pwa900
   Updated: 2022-09-24    RAS profile: 2021-09-17    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Asaria, Miqdad (4)

Revill, Paul (3)

Authors registered in RePEc who have co-authored more than one work in the last five years with Simon Walker.

Is cited by:

Brouwer, Werner (13)

Claxton, Karl (13)

Sculpher, Mark (10)

van Exel, Job (6)

Revill, Paul (5)

Culyer, Anthony (3)

EPSTEIN, DAVID (2)

Shah, Koonal (2)

Towse, Adrian (2)

Attema, Arthur (2)

Asaria, Miqdad (2)

Cites to:

Claxton, Karl (24)

Asaria, Miqdad (21)

Sculpher, Mark (19)

Tsuchiya, Aki (10)

Culyer, Anthony (9)

Rice, Nigel (8)

Brouwer, Werner (7)

Revill, Paul (5)

McCabe, Christopher (4)

EPSTEIN, DAVID (4)

Devlin, Nancy (3)

Main data


Where Simon Walker has published?


Journals with more than one article published# docs
PharmacoEconomics5
PharmacoEconomics - Open2
Health Economics2

Working Papers Series with more than one paper published# docs
Working Papers / Centre for Health Economics, University of York8

Recent works citing Simon Walker (2022 and 2021)


YearTitle of citing document
2022Estimating the optimal individualized treatment rule from a cost?effectiveness perspective. (2022). Shen, Jincheng ; Moran, Andrew E ; Weintraub, William S ; Zhang, Yue ; Bellows, Brandon K ; Sauer, Brian C ; Bress, Adam P ; Greene, Tom H ; Xu, Yizhe. In: Biometrics. RePEc:bla:biomet:v:78:y:2022:i:1:p:337-351.

Full description at Econpapers || Download paper

2021Taking a local government perspective for economic evaluation of a population-level programme to promote exercise. (2021). Bojke, Laura ; Hill, Andrew J ; Meads, David ; Candio, Paolo. In: Health Policy. RePEc:eee:hepoli:v:125:y:2021:i:5:p:651-657.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review. (2021). Phelps, Charles E ; Chen, Hui-Han ; Padula, William V. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:2:d:10.1007_s40258-020-00606-4.

Full description at Econpapers || Download paper

2022Avoiding Opportunity Cost Neglect in Cost-Effectiveness Analysis for Health Technology Assessment. (2022). Faria, Rita ; Ochalek, Jessica ; Lomas, James. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00679-9.

Full description at Econpapers || Download paper

2021State of the ART? Two New Tools for Risk Communication in Health Technology Assessments. (2021). Grutters, Janneke ; Otten, Thomas ; Wijnen, Ben ; Pouwels, Xavier ; Grimm, Sabine E ; Joore, Manuela A. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:10:d:10.1007_s40273-021-01060-3.

Full description at Econpapers || Download paper

2021The Relative Importance of Education and Criminal Justice Costs and Benefits in Economic Evaluations: A Best–Worst Scaling Experiment. (2021). , Ruben ; Silvia, ; Hiligsmann, Mickael ; Pokhilenko, Irina. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:1:d:10.1007_s40273-020-00966-8.

Full description at Econpapers || Download paper

2021Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs. (2021). Sauboin, Christophe ; Standaert, Baudouin ; Connolly, Mark P ; Leclerc, Quentin J. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00978-4.

Full description at Econpapers || Download paper

2022In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era. (2022). Exel, Job ; Roijen, Leona Hakkaart-Van ; Kanters, Tim ; Sajjad, Ayesha ; Huls, Samare ; Brouwer, Werner. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:1:d:10.1007_s40273-021-01117-3.

Full description at Econpapers || Download paper

Works by Simon Walker:


YearTitleTypeCited
2019Incorporating concerns for equity into health resource allocation. A guide for practitioners In: Working Papers.
[Full Text][Citation analysis]
paper0
2019Economic analysis for health benefits package design In: Working Papers.
[Full Text][Citation analysis]
paper0
2019Applying the three core concepts of economic evaluation in health to education in the UK In: Working Papers.
[Full Text][Citation analysis]
paper0
2020Does Health Technology Assessment guidance give adequate consideration to decisions about less costly and less effective alternatives? In: Working Papers.
[Full Text][Citation analysis]
paper0
2021Comparing smoking cessation to screening and brief intervention for alcohol in distributional cost effectiveness analysis to explore the sensitivity of results to socioeconomic inequalities characteri In: Working Papers.
[Full Text][Citation analysis]
paper0
2010Appropriate Perspectives for Health Care Decisions In: Working Papers.
[Full Text][Citation analysis]
paper44
2012Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions In: Working Papers.
[Full Text][Citation analysis]
paper22
2014Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose? In: Working Papers.
[Full Text][Citation analysis]
paper9
2019Striving for a societal perspective: a framework for economic evaluations when costs and effects fall on multiple sectors and decision-makers In: LSE Research Online Documents on Economics.
[Full Text][Citation analysis]
paper9
2019Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers.(2019) In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 9
article
2016Using electronic health records to predict costs and outcomes in stable coronary artery disease In: LSE Research Online Documents on Economics.
[Full Text][Citation analysis]
paper3
2015Sustainable HIV treatment in Africa through viral-load-informed differentiated care In: Nature.
[Full Text][Citation analysis]
article0
2018Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated care In: PLOS ONE.
[Full Text][Citation analysis]
article0
2017How to Invest in Getting Cost-effective Technologies into Practice? A Framework for Value of Implementation Analysis Applied to Novel Oral Anticoagulants In: Medical Decision Making.
[Full Text][Citation analysis]
article2
2018Establishing the Value of Diagnostic and Prognostic Tests in Health Technology Assessment In: Medical Decision Making.
[Full Text][Citation analysis]
article1
2020Impact of Socioeconomic Differences on Distributional Cost-effectiveness Analysis In: Medical Decision Making.
[Full Text][Citation analysis]
article0
2021Uncertainty Analysis in Intervention Impact on Health Inequality for Resource Allocation Decisions In: Medical Decision Making.
[Full Text][Citation analysis]
article0
2017Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2012Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6–11 Years In: PharmacoEconomics.
[Full Text][Citation analysis]
article3
2016Using Linked Electronic Health Records to Estimate Healthcare Costs: Key Challenges and Opportunities In: PharmacoEconomics.
[Full Text][Citation analysis]
article5
2016Using Linked Electronic Health Records to Estimate Healthcare Costs: Key Challenges and Opportunities.(2016) In: PharmacoEconomics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 5
article
2019An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis In: PharmacoEconomics.
[Full Text][Citation analysis]
article3
2021Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2018Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
article1
2019Correction to: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
article0
2020Distributional cost effectiveness analysis of West Yorkshire low emission zone policies In: Health Economics.
[Full Text][Citation analysis]
article0
2021Cost?effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross?sectoral analysis of an alcohol misuse intervention In: Health Economics.
[Full Text][Citation analysis]
article1

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated August, 1st 2022. Contact: CitEc Team